Niagen Bioscience, Inc. (NAGE) Ownership

NASDAQ: NAGETop holders, insider trades and short interest.

NAGE ownership summary

as of October 18, 2026
Institutions
41.6%
of shares outstanding
Insiders
29.45%
of shares outstanding
Shares outstanding
79.1M
Float
59.1M
shares available to trade
Short interest
7.54%
3.9M shares short
Days to cover
10.10
short interest down 3.1% vs prior month
  • Institutions 41.58%
  • Insiders 29.45%
  • Other investors 28.96%

NAGE top institutional holders

20 largest
Niagen Bioscience, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1BlackRock Inc5.29%4.2M$10.4M+313,040 (+8.1%)June 30, 2026
2Steel Peak Wealth Management LLC4.42%3.5M$8.7M+127,129 (+3.8%)June 30, 2026
3Vanguard Capital Management, LLC2.71%2.1M$5.3M−2,259 (−0.1%)June 30, 2026
4Tieton Capital Management, LLC2.54%2.0M$5.0M−20,685 (−1.0%)June 30, 2026
5Qube Research & Technologies2.05%1.6M$4.0M−89,623 (−5.2%)June 30, 2026
6Geode Capital Management, LLC1.87%1.5M$3.7M+133,682 (+9.9%)June 30, 2026
7UBS Group AG1.62%1.3M$3.2M−122,235 (−8.7%)June 30, 2026
8The Goldman Sachs Group Inc1.60%1.3M$3.1M+10,784 (+0.9%)June 30, 2026
9Arrowstreet Capital Limited Partnership1.48%1.2M$2.9M−1.2M (−50.8%)June 30, 2026
10Vanguard Portfolio Management, LLC1.47%1.2M$2.9M−55,261 (−4.5%)June 30, 2026
11State Street Corp1.37%1.1M$2.7M−1,813 (−0.2%)June 30, 2026
12Renaissance Technologies Corp0.83%660K$1.6M−669,259 (−50.4%)June 30, 2026
13Citadel Advisors Llc0.80%630K$1.6M+99,632 (+18.8%)June 30, 2026
14Dimensional Fund Advisors, Inc.0.77%605K$1.5M−465,807 (−43.5%)June 30, 2026
15Morgan Stanley - Brokerage Accounts0.64%505K$1.3M+123,683 (+32.5%)June 30, 2026
16Los Angeles Capital Management LLC0.61%481K$1.2M+355,254 (+281.5%)March 31, 2026
17Victory Capital Management Inc.0.60%473K$1.2M+47,950 (+11.3%)June 30, 2026
18AQR Capital Management LLC0.60%472K$1.2M−559,279 (−54.2%)June 30, 2026
19SEI Investments Co0.60%472K$1.2M−499,640 (−51.4%)June 30, 2026
20Northern Trust Corp0.59%467K$1.2M+70,653 (+17.8%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 9 holders added 1.3M shares and 11 cut 3.7M.

NAGE top mutual fund and ETF holders

20 largest
Niagen Bioscience, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1iShares Russell 2000 ETF1.89%1.5M$3.7M−17,280 (−1.1%)September 30, 2026
2Vanguard MStar Total Stk Mkt Idx Invest1.86%1.5M$3.7M—August 31, 2026
3Fidelity Small Cap Index0.79%626K$1.6M−771 (−0.1%)July 31, 2026
4Vanguard Consumer Staples ETF0.75%595K$1.5M−2,886 (−0.5%)August 31, 2026
5iShares Russell 2000 Growth ETF0.69%548K$1.4M−694 (−0.1%)September 30, 2026
6Vanguard Russell 2000 ETF0.42%332K$825,537+6,600 (+2.0%)August 31, 2026
7Schwab US Small-Cap ETF™0.38%302K$750,929+198 (+0.1%)September 30, 2026
8Fidelity Extended Market Index0.36%284K$707,334+9,470 (+3.4%)August 31, 2026
9Victory Small Cap Stock0.36%283K$703,801—June 30, 2026
10VictoryShares Small Cap Fr CA Flw ETF0.34%272K$676,675—September 30, 2026
11iShares Micro-Cap ETF0.23%183K$454,960−1,260 (−0.7%)September 30, 2026
12Vanguard Explorer Inv0.21%169K$419,941—June 30, 2026
13Gabelli Equity Trust0.19%151K$375,990+7,000 (+4.9%)June 30, 2026
14Schwab Small Cap Index0.18%141K$351,122—August 31, 2026
15Amplify Etho Climate Leadership U.S. ETF0.17%134K$334,377+7,899 (+6.2%)September 30, 2026
16PV BUYBACK USA Classe B USD0.16%130K$323,700—June 30, 2026
17iShares Russell 2000 Small-Cap Idx Instl0.16%125K$311,073+7,439 (+6.3%)August 31, 2026
18Aviva Investors Mlt-Strat Trgt Ret 2£Acc0.14%115K$285,429+6,842 (+6.3%)August 31, 2026
19Fidelity Total Market Index0.13%103K$256,985—August 31, 2026
20Goldman Sachs ActiveBeta® US SmCp Eq ETF0.13%102K$254,939—September 30, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

NAGE insider transactions

latest 2
Niagen Bioscience, Inc. insider transactions
DateNameTransactionPriceSharesValue
2025-11-14Ozan PamirBuy$6.814,465$30,407
2025-11-14Ozan PamirBuy$6.852,220$15,207

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

NAGE shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns NAGE

Institutional investors own 41.6% of Niagen Bioscience's shares and insiders 29.45%. The largest holder is BlackRock Inc with 5.29% of the shares (4.2M), as of June 30, 2026. Among the top 20 institutions, 9 added shares and 11 reduced their stake in the latest filings. Short interest is 7.54% of the float, or 10.10 days of average trading volume. The share count rose 137.1% since 2014.

Related: NAGE analyst forecast, NAGE key metrics. See the NAGE stock overview for the latest quote and news.

NAGE ownership FAQ

Who owns the most Niagen Bioscience stock?

The largest shareholders of Niagen Bioscience are BlackRock Inc (5.29%), Steel Peak Wealth Management LLC (4.42%), Vanguard Capital Management, LLC (2.71%), Tieton Capital Management, LLC (2.54%), Qube Research & Technologies (2.05%).

What percentage of Niagen Bioscience is owned by institutions?

Institutions hold 41.6% of Niagen Bioscience's shares outstanding; insiders hold 29.45%.

Which funds own Niagen Bioscience?

The largest fund holders of Niagen Bioscience are iShares Russell 2000 ETF (1.89%), Vanguard MStar Total Stk Mkt Idx Invest (1.86%), Fidelity Small Cap Index (0.79%), Vanguard Consumer Staples ETF (0.75%), iShares Russell 2000 Growth ETF (0.69%).

What is Niagen Bioscience's short interest?

3.9M shares of Niagen Bioscience were sold short, 7.54% of the float; at the average daily volume it would take 10.10 days to cover.

Are insiders buying or selling Niagen Bioscience?

Of the latest 2 reported insider transactions in Niagen Bioscience (since November 14, 2025), 2 were purchases and 0 were sales.

How many shares of Niagen Bioscience are outstanding?

Niagen Bioscience has 79.1M shares outstanding, of which 59.1M are in the public float.

Packaged Foods: ownership